Tirofiban before clot removal for large artery stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether adding a clot-preventing medication called tirofiban before a mechanical clot removal procedure can improve recovery in people with a certain type of stroke. It's for those with a large artery blockage in the front part of the brain who are able to start the procedure within 12 hours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a stroke caused by a clot in a large artery in the front part of your brain.
- You can start the clot removal procedure within 12 hours of when your symptoms began.
- Your stroke should be moderate to severe, scoring 6 or higher on the NIH stroke scale.
- Your brain scan (CT) must show a score of 6 or higher on a scale that measures early damage.
- Before this stroke, you were able to do most daily activities without help (score 0-2 on a prior disability scale).
- You cannot have certain heart rhythm problems, recent bleeding, or have taken specific blood thinners recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a drug called tirofiban can help people who had a stroke more than 24 hours ago but within 7 days. It is for strokes caused by a buildup of plaque in a large brain artery, and uses a special MRI to confirm the cause.
This trial tests whether a specific head-down position before a clot removal procedure improves outcomes for people with a large vessel occlusion stroke. It is for patients who have a confirmed blockage and can wait a short time before the procedure.
This trial tests if adding a blood thinner called tirofiban after successful clot removal can improve recovery in people with severe stroke. It is for patients who had a large blockage and are treated within 24 hours of symptoms starting.
This trial tests whether giving either tirofiban or alteplase through a vein before a mechanical clot-removal procedure works better for an acute ischemic stroke. It may help improve how well blood flow returns and how much recovery patients can have after treatment.
This trial tests adding the anti-clotting drug tirofiban to standard clot removal for people who have a stroke due to a narrowed artery in the brain. The goal is to see if this combination improves outcomes without raising bleeding risk.
This trial tests whether injecting a blood thinner called tirofiban directly into brain blood vessels during a stroke procedure helps prevent clots from forming again. If you've had a stroke caused by a large clot in your brain that was successfully removed, this study may help protect your recovery.
Hear when a new Stroke, Ischemic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.